文献速递新发突发、热带与寄生虫病

用血清学标志物预测间日疟显微镜检出发作风险的多国诊断性能评估

Predicting Risk of Plasmodium Vivax Microscopy-Detected Episodes Using Serological Markers in Patients With Plasmodium falciparum Malaria: A Multicountry Diagnostic Performance Evaluation.
PubMed 文献 · J Infect Dis · 2026-01-01

本研究基于PRIMA研究在埃塞俄比亚、印度尼西亚和孟加拉国的参与者样本,评估间日疟血清学暴露标志物(SEMs)作为筛查工具,在恶性疟患者中预测未来63天内间日疟显微镜检出发作风险的能力。结果显示SEMs灵敏度高(82%)但特异度低(27%),研究特异性算法可将特异度提高至68%但灵敏度相应降至68%。结论认为SEMs在此场景下指导根治治疗的适用性有限。

要点

  • 间日疟SEMs在恶性疟患者中预测63天内间日疟发作的灵敏度为82%,特异度仅27%。
  • 研究特异性算法优化后特异度升至68%,但灵敏度降至68%。
  • SEMs在此场景下指导普遍根治的适用性有限,或有助于社区接受度。

核心结论

  • 间日疟血清学暴露标志物在恶性疟患者中预测间日疟显微镜检出发作的适用性有限。
  • 在强沟通和实施策略支持下,SEMs可能有助于建立社区对普遍根治的信任和接受度。

研究设计与样本

  • 基于PRIMA研究(NCT03916003)在埃塞俄比亚、印度尼西亚和孟加拉国的参与者样本。
  • 评估间日疟血清学暴露标志物作为筛查工具,预测恶性疟患者未来63天内间日疟显微镜检出发作的风险。
  • 使用现有随机森林血清学分类算法评估灵敏度和特异度,并通过重新训练研究特异性模型进一步优化。

主要发现

  • 共测量244份恶性疟参与者样本的IgG抗体,其中22例在随访期间出现间日疟显微镜检出发作。
  • 血清学暴露标志物显示高灵敏度(82%)但低特异度(27%)。
  • 低特异度可能由于中高传播地区持续性抗体反应或随访期间未检测到的亚微观间日疟感染。
  • 研究特异性算法将特异度提高至68%,但灵敏度相应降至68%。

临床怎么用

  • 基于当前性能,SEMs在此场景下尚不适合单独指导恶性疟患者的普遍根治决策。
  • 在强沟通和实施策略支持下,SEMs或可用于提升社区对普遍根治的信任和接受度。

局限性

  • 结局为显微镜检出的间日疟发作,可能遗漏亚微观感染。
  • 中高传播地区的持续性抗体反应可能影响特异度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Plasmodium vivax presents a significant obstacle to malaria elimination due to its capacity to form dormant liver-stage hypnozoites that can cause relapses. Universal radical cure, which administers hypnozoite-targeting treatment to patients with P. falciparum malaria living in co-endemic areas, has potential to reduce P. vivax relapses. However, its implementation is hindered by the lack of a diagnostic tool for detecting hypnozoite-carriage. METHODS: P. vivax serological exposure markers (SEMs) were evaluated as a screening tool in P. falciparum patients for predicting risk of P. vivax microscopy-detected episodes over the following 63 days. Analysis was performed using samples from participants in the PRIMA study from Ethiopia, Indonesia, and Bangladesh (NCT03916003). An existing random forest serological classification algorithm was used and evaluated for sensitivity and specificity, then further optimized by re-training a study-specific model. RESULTS: IgG antibodies were measured in 244 P. falciparum participant samples, of which 22 had a vivax microscopy-detected episode during follow-up. Serological exposure markers showed high sensitivity (82%) but low specificity (27%), likely due to sustained antibody responses in moderate-to-high transmission areas or undetected submicroscopic P. vivax infections during follow-up. A study-specific algorithm increased specificity to 68%, but with a corresponding drop in sensitivity to 68%. CONCLUSIONS: Although P. vivax SEMs showed limited suitability for guiding radical cure in P. falciparum patients in this study (where the outcome was microscopy-detected vivax episodes), they could play a valuable role in building community trust and acceptance of universal radical cure when supported by strong communication and implementation strategies.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hafidzah M, Degaga TS, Christian M, et al. Predicting Risk of Plasmodium Vivax Microscopy-Detected Episodes Using Serological Markers in Patients With Plasmodium falciparum Malaria: A Multicountry Diagnostic Performance Evaluation. J Infect Dis. 2026. PMID: 41846579. doi:10.1093/infdis/jiag164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。